Drugs already taken by millions of diabetes patients appear to also help slash asthma attacks by up to 70%, new British research shows.

In his recent doctoral thesis, defended at the University of Helsinki, Matej Zore investigated two drugs, fingolimod and etrasimod—initially developed to treat autoimmune diseases—for their potential ...

Revuforj is the first so-called menin inhibitor cleared in the U.S., securing FDA approval for use in adults and certain ...

The U.S. patient population for Revuforj in its approved indication is roughly 2,000 according to Syndax. KMT2A leukemias ...

FoundationOne Liquid CDx is now FDA-approved to identify mNSCLC patients with MET exon 14 skipping alterations for tepotinib ...

Myasthenia gravis treatment aims to minimize the effects of muscle weakness due to an immune process. It includes medications ...

Amgen today announced the presentation of new data across its rare disease portfolio and pipeline at the annual American College of Rheumatology (ACR) Convergence 2024 conference in Washington, D.C., ...